We observed that brief pretreatment with GLP-1(2836) versus the scrambled control increased glycolysis by 36% (extracellular acidification rate [ECAR]: 14.5 1.6 vs
Interestingly, this effect appears to be context-dependent, that is, robust in vivo, but not consistently observed in isolated in vitro models
These findings could suggest that the effect of liraglutide on hyperandrogenism does not depend exclusively on weight loss, it can also occur at low doses, and that there is probably a synergistic action with metformin
They help: Stimulate insulin production after meals (lowering blood sugar) Slow gastric emptying (so patients feel full longer) Reduce appetite through direct effects on the brain While originally approved for type 2 diabetes, some GLP1s, such as Saxenda, Wegovy and Zepbound, carry FDA approval for weight loss in adults with a BMI of 30 or more, or 27 with other health issues like high blood pressure or cholesterol
End of story